Stock listing

NASDAQ:VIVS VivoSim Labs, Inc. Stock

Home listing (NASDAQ) of VivoSim Labs, Inc.

Follow VivoSim Labs, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:VIVS

$0.261 USD -0.031 (-10.5%)

Close on Nov 20, 2026

Past year -88.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.244 – $0.381 USDNov 20, 2026
Volume
149.2M sharesNov 20, 2026
Market cap
$5.29M USDAt the close on Nov 20, 2026 · price × 20.28M shares outstanding
52-week range
$0.118 – $3.400 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$4.37M USDMedian day 560,200 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
VivoSim Labs, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:VIVS · Home$0.261 USD-0.031 (-10.5%)149,183,534$0.280$0.381$0.244$0.292Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:VIVS · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.261-0.031-10.5%$0.280$0.381$0.244149,183,534
$0.292+0.171+142.9%$0.195$0.323$0.169815,947,375
$0.1200.000-0.1%$0.120$0.126$0.119264,657
$0.120-0.004-2.9%$0.123$0.126$0.118249,571
$0.124-0.006-4.8%$0.131$0.131$0.122231,880
$0.130-0.010-7.1%$0.140$0.140$0.130451,100
$0.140-0.010-6.7%$0.160$0.160$0.1301,614,900
$0.150+0.020+15.4%$0.130$0.180$0.1306,966,800
$0.130-0.010-7.1%$0.150$0.150$0.120561,400
$0.1400.0000.0%$0.140$0.150$0.140369,300
$0.1400.0000.0%$0.140$0.140$0.140160,600
$0.140-0.010-6.7%$0.150$0.150$0.140527,300
$0.150+0.010+7.1%$0.160$0.160$0.140540,900
$0.140-0.010-6.7%$0.150$0.150$0.1401,513,500
$0.1500.0000.0%$0.150$0.160$0.150531,800
$0.150-0.010-6.3%$0.150$0.160$0.140755,800
$0.160+0.010+6.7%$0.150$0.170$0.1502,566,200
$0.1500.0000.0%$0.150$0.150$0.140320,100
$0.1500.0000.0%$0.160$0.160$0.150476,200
$0.1500.0000.0%$0.150$0.160$0.140566,900
$0.150-0.010-6.3%$0.150$0.160$0.140745,500
$0.160-0.020-11.1%$0.180$0.180$0.1502,658,100
$0.180+0.010+5.9%$0.160$0.180$0.1602,647,900
$0.170+0.010+6.3%$0.160$0.180$0.160692,300
$0.1600.0000.0%$0.160$0.160$0.160357,200
$0.160-0.010-5.9%$0.160$0.170$0.150822,900
$0.170+0.010+6.3%$0.160$0.190$0.1503,512,500
$0.160-0.010-5.9%$0.170$0.170$0.160356,600
$0.1700.0000.0%$0.180$0.180$0.170181,000
$0.170-0.010-5.6%$0.180$0.180$0.1701,096,800
$0.1800.0000.0%$0.180$0.180$0.170332,200
$0.180-0.010-5.3%$0.190$0.190$0.170872,700
$0.190-0.010-5.0%$0.200$0.210$0.190881,200
$0.200-0.010-4.8%$0.210$0.210$0.200374,900
$0.210+0.010+5.0%$0.200$0.210$0.190444,300
$0.200-0.010-4.8%$0.210$0.210$0.190804,500
$0.2100.0000.0%$0.210$0.220$0.210185,300
$0.210+0.010+5.0%$0.200$0.220$0.200558,100
$0.200-0.020-9.1%$0.230$0.230$0.200647,800
$0.2200.0000.0%$0.230$0.230$0.220423,900
$0.220-0.010-4.3%$0.230$0.230$0.220253,000
$0.2300.0000.0%$0.230$0.230$0.220559,000
$0.230-0.010-4.2%$0.240$0.240$0.220615,400
$0.240-0.010-4.0%$0.250$0.260$0.2301,242,600
$0.250+0.020+8.7%$0.230$0.260$0.2201,451,300
$0.230-0.030-11.5%$0.260$0.260$0.2201,568,400
$0.2600.0000.0%$0.270$0.270$0.260595,100
$0.260-0.010-3.7%$0.270$0.270$0.2506,387,800
$0.270-0.010-3.6%$0.280$0.280$0.270304,700
$0.2800.0000.0%$0.290$0.290$0.270389,100
$0.280-0.020-6.7%$0.300$0.300$0.280419,900
$0.300+0.020+7.1%$0.280$0.300$0.2701,401,200
$0.2800.0000.0%$0.280$0.290$0.270398,200
$0.2800.0000.0%$0.280$0.290$0.270696,900
$0.2800.0000.0%$0.280$0.280$0.280267,900
$0.2800.0000.0%$0.280$0.280$0.270606,300
$0.2800.0000.0%$0.280$0.280$0.270386,600
$0.280-0.010-3.4%$0.300$0.300$0.270366,400
$0.2900.0000.0%$0.290$0.290$0.280358,800
$0.2900.0000.0%$0.290$0.300$0.290230,800
$0.2900.0000.0%$0.290$0.300$0.280333,000
$0.290-0.002-0.5%$0.290$0.300$0.280283,100
$0.2920.000-0.1%$0.287$0.300$0.281647,948
$0.292+0.002+0.7%$0.284$0.304$0.276969,780
$0.290+0.010+3.6%$0.280$0.290$0.270715,800
$0.2800.0000.0%$0.280$0.280$0.270803,200

Splits

2 splits since 2020 · NASDAQ:VIVS · every price before a split is adjusted for it

DayRatioWhat
1-for-12Consolidation
1-for-20Consolidation
Ticker
NASDAQ:VIVS
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All VivoSim Labs, Inc. news

VivoSim Labs, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
23 in the last 12 months · 69 in all · newest Nov 19, 2026 · oldest 2019
Decks
1 deck · latest 2026

Where VivoSim Labs, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:VIVS · Home listing · This pageNASDAQUnited StatesUSD
Munich:4ORMunichGermanyEUR
LSE:0R02LSEUnited KingdomUSD
gettex:4ORgettexGermanyEUR
BOATS:VIVSBOATSUnited StatesUSD
Frankfurt:4ORFrankfurtGermanyEUR
LS Exchange:A41083LS ExchangeGermanyEUR
Lang & Schwarz:A41083Lang & SchwarzGermanyEUR
Stuttgart:4ORStuttgartGermanyEUR

Valuation

EV/sales −20.5× against a median of 1.6×: the lowest of 10 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$2.76M USD
P/E
Loss
EV/sales
−20.5×
EV/EBITDA
Negative EBITDA
Price/book
0.7×
Gross margin
Revenue too small
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.1×
Beta vs S&P 500
1.91

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
VivoSim Labs, Inc. · NASDAQ:VIVSUS$5.29M−US$2.76Mn/a−20.5×n/a0.7×n/a0.1×1.91
iXensor Co., Ltd. · TPEX:6734US$6.01MUS$5.63Mn/a6.9×n/a23.1×−174.7%0.9×n/a
Cizzle Biotechnology Holdings PLC · LSE:CIZUS$5.70MUS$5.59Mn/an/an/an/an/an/an/a
AcouSort AB · OMXSTO:ACOUUS$5.69MUS$4.76Mn/a6.1×n/a5.9×−140.8%0.0×n/a
GENinCode PLC · LSE:GENIUS$5.42MUS$2.86Mn/a0.7×n/a2.0×−185.5%0.1×n/a
Nanologica AB · OMXSTO:NICAUS$5.29MUS$8.67M2.9×1.6×n/a0.3×34.9%0.3×n/a
Biomerica, Inc. · NASDAQ:BMRAUS$4.97MUS$2.23Mn/a0.5×n/a1.4×−115.5%0.0×0.71
VolitionRx Limited · AMEX:VNRXUS$4.87MUS$9.19Mn/a2.7×n/an/a−698.5%n/a1.52
Boule Diagnostics AB · OMXSTO:BOULUS$4.84MUS$24.70Mn/a0.6×n/a0.3×−4.0%1.3×n/a
BioInfra Co.,Ltd. · KRX:199730US$4.75M−US$509,202n/a−0.0×n/a0.5×−32.3%0.0×n/a
Cardio Diagnostics Holdings Inc. · NASDAQ:CDIOUS$4.74MUS$4.74Mn/a312×n/a0.8×n/a0.0×2.07
Median of the othersUS$5.13MUS$5.18M2.9×1.6×1.1×−128.1%0.0×1.52

Team and board

Officers

OfficerRole
Doug CohenChief Executive Officer
Norman StaskeyChief Financial Officer
Amar A. SethiChief Science Officer
Keith MurphyExecutive Chairman
Tony LialinChief Commercial Officer

Board

DirectorRole
Keith MurphyExecutive Chairman
Adam K. SternDirector
Alison MilhousDirector
David GobelDirector

Events

QuarterResultsShare move
Q2 2027Nov 12, 2026−13.3%
Q1 2027Aug 12, 2026−5.7%
Q4 2026Jun 25, 2026−5.5%
Q3 2026Feb 27, 2026−1.4%
Q2 2026Nov 6, 2025−4.4%
Q1 2026Aug 12, 2025+4.5%
Q4 2025May 22, 2025+1.5%
Q3 2025Feb 19, 2025 · Before open0.0%
Q2 2025Nov 8, 2024 · After close0.0%
Q1 2025Aug 5, 2024 · After close0.0%
All 20 quarters
QuarterResultsShare move
Q4 2024May 10, 2024 · After close+3.3%
Q3 2024Feb 8, 2024 · After close−10.0%
Q2 2024Nov 9, 2023 · After close−7.5%
Q1 2024Aug 10, 2023−0.6%
Q4 2023May 25, 2023+7.9%
Q3 2023Feb 9, 2023+6.7%
Q2 2023Nov 10, 2022+7.3%
Q1 2023Aug 11, 2022−2.1%
Q4 2022May 26, 2022+1.7%
Q3 2022Feb 8, 2022−7.7%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (2026)Investor deck22 slides2026

Open Decks

Financings

RaiseDate
Private placement of pre-funded warrants and common warrants
Closed: US$4M raised · US$0.85 a share · Warrants at US$0.85 for 60 months · A.G.P./Alliance Global Partners
Dealers: A.G.P./Alliance Global Partners (lead)
Use of proceeds: Working capital and general corporate purposes
Aug 6, 2026
Warrant exercise of common stock issued on warrant exercises and at-the-market sales
Closed: US$2.3M raised
Mar 6, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue131.0K144.0K109.0K370.0K1.50M02.20M3.09M4.60M4.23M
Cost of revenue05.00K00300.0K500.0K1.00M956.0K
Gross profit131.0K139.0K109.0K370.0K1.50M01.87M2.61M3.57M3.27M
Research and development4.19M5.03M5.50M8.88M3.32M1.10M5.28M14.8M18.0M19.5M
Selling, general and administrative7.43M7.73M9.70M9.22M9.66M15.7M18.1M15.1M20.9M22.3M
Operating income-11.5M-12.6M-15.1M-17.7M-11.5M-16.8M-21.5M-27.3M-35.3M-38.6M
Depreciation and amortization215.0K266.0K280.0K293.0K142.0K41.0K1.14M980.0K1.27M1.15M
EBITDA-11.3M-12.3M-14.8M-17.4M-11.3M-16.8M-20.3M-26.3M-34.0M-37.4M
Interest expense12.0K10.0K00
Income before tax-13.8M-2.49M-14.7M-17.3M-11.4M-16.8M-18.7M-26.6M-34.8M-38.4M
Income tax2.00K2.00K2.00K2.00K2.00K2.00K2.00K3.00K2.00K23.0K
Net income-13.8M-2.49M-14.7M-17.3M-11.4M-16.8M-18.7M-26.6M-34.8M-38.4M
Earnings per share, basic-5.35-1.70-19.25-1.98-1.32-2.44-2.80-0.23-0.32-0.39
Earnings per share, diluted-5.35-1.70-19.25-1.98-1.32-2.44-2.80-0.23-0.32-0.39

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents5.02M11.3M2.90M15.3M28.7M37.4M27.4M36.5M43.7M62.8M
Short-term investments0706.0K0
Receivables32.0K30.0K33.0K152.0K00111.0K503.0K883.0K647.0K
Inventory00297.0K00490.0K842.0K550.0K
Current assets6.63M12.1M3.94M17.0M29.5M38.4M28.3M38.6M46.8M65.1M
Property, plant and equipment206.0K419.0K669.0K902.0K662.0K381.0K01.83M2.79M3.84M
Total assets7.39M14.7M6.35M20.3M33.3M39.9M28.4M40.6M49.8M69.2M
Accounts payable1.02M1.64M627.0K331.0K415.0K281.0K720.0K628.0K464.0K1.17M
Current liabilities2.79M3.74M1.86M3.67M1.38M721.0K1.81M3.74M4.66M6.01M
Total debt447.0K942.0K1.39M1.80M2.18M
Total liabilities8.48M4.16M2.75M4.98M3.09M721.0K1.81M4.33M5.24M6.82M
Shareholders' equity-1.10M10.5M3.60M15.3M30.2M39.2M26.6M36.3M44.6M62.4M
Shares outstanding2.89M1.90M839.8K8.72M8.71M8.67M6.53M124.0M111.0M104.6M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-10.8M-9.46M-14.7M-12.4M-8.45M-13.3M-14.9M-20.4M-28.9M-29.2M
Capital spending0-13.0K-42.0K-396.0K-409.0K-405.0K0-79.0K-226.0K-1.35M
Free cash flow-10.8M-9.47M-14.7M-12.8M-8.86M-13.7M-14.9M-20.5M-29.1M-30.5M
Cash from investing94.0K9.03M816.0K-966.0K-409.0K-393.0K747.0K-76.0K-292.0K-1.39M
Cash from financing4.45M8.85M1.44M0205.0K23.8M4.93M13.2M10.1M31.2M
Share buybacks0-1.00K0
Change in cash-6.29M8.41M-12.4M-13.4M-8.66M10.1M-9.20M-7.30M-19.0M660.0K

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 12, 2026Quarterly reportSEC
8-K · Current reportOct 16, 2026Material contractSEC
8-K · Current reportOct 6, 2026Management or board changeSEC
4 · Change in ownershipSep 1, 2026Insider tradeSEC
ARS · Annual report to shareholdersAug 21, 2026Annual reportSEC
8-K · Current reportAug 21, 2026Current reportSEC
DEF 14A · Proxy statementAug 21, 2026Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 17, 2026Big-stake noticeSEC
PRER14AAug 13, 2026Other filingsSEC
10-Q · Quarterly reportAug 12, 2026Quarterly reportSEC
Show 200 filings
FilingDateTypeFiled with
EFFECT · Notice that a registration is effectiveAug 11, 2026Other filingsSEC
PRE 14A · Preliminary proxy statementAug 10, 2026Meeting noticeSEC
8-K · Current reportAug 6, 2026ResultsSEC
S-1 · Registration statementJul 31, 2026Offer documentSEC
8-K · Current reportJul 30, 2026Current reportSEC
8-K · Current reportJul 24, 2026Current reportSEC
8-K · Current reportJul 17, 2026Material contractSEC
10-K · Annual reportJul 14, 2026Annual reportSEC
NT 10-K · Late filing noticeJun 29, 2026Explanation requestSEC
SCHEDULE 13G · Big-stake noticeApr 6, 2026Big-stake noticeSEC
8-K · Current reportApr 3, 2026Material contractSEC
424B4 · ProspectusApr 2, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveApr 1, 2026Other filingsSEC
CORRESP · Letter to the SECMar 31, 2026Other filingsSEC
CORRESP · Letter to the SECMar 31, 2026Other filingsSEC
S-1/A · Registration statement, amendedMar 31, 2026Offer documentSEC
CORRESP · Letter to the SECMar 30, 2026Other filingsSEC
CORRESP · Letter to the SECMar 30, 2026Other filingsSEC
CORRESP · Letter to the SECMar 27, 2026Other filingsSEC
CORRESP · Letter to the SECMar 27, 2026Other filingsSEC
S-1 · Registration statementMar 27, 2026Offer documentSEC
UPLOAD · Letter from the SECMar 13, 2026Other filingsSEC
DRS · Draft registration statementMar 9, 2026Offer documentSEC
10-Q · Quarterly reportFeb 11, 2026Quarterly reportSEC
4 · Change in ownershipJan 29, 2026Insider tradeSEC
4 · Change in ownershipJan 29, 2026Insider tradeSEC
4 · Change in ownershipJan 29, 2026Insider tradeSEC
4 · Change in ownershipJan 29, 2026Insider tradeSEC
4 · Change in ownershipJan 29, 2026Insider tradeSEC
8-K · Current reportDec 18, 2025Meeting outcomeSEC
4 · Change in ownershipNov 26, 2025Insider tradeSEC
3 · Initial statement of ownershipNov 26, 2025Insider tradeSEC
4 · Change in ownershipNov 19, 2025Insider tradeSEC
ARS · Annual report to shareholdersNov 6, 2025Annual reportSEC
10-Q · Quarterly reportNov 6, 2025Quarterly reportSEC
DEFA14A · Additional proxy materialNov 3, 2025Meeting noticeSEC
DEF 14A · Proxy statementNov 3, 2025Meeting noticeSEC
RW · Request to withdraw a registrationSep 25, 2025Other filingsSEC
S-8 · Registration statement for employee plansAug 28, 2025Offer documentSEC
4 · Change in ownershipAug 21, 2025Insider tradeSEC
3 · Initial statement of ownershipAug 21, 2025Insider tradeSEC
8-K · Current reportAug 14, 2025Management or board changeSEC
10-Q · Quarterly reportAug 12, 2025Quarterly reportSEC
10-K/A · Annual report, amendedJul 29, 2025Annual reportSEC
10-K · Annual reportJun 5, 2025Annual reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
8-K · Current reportMay 6, 2025Current reportSEC
8-K · Current reportApr 24, 2025Current reportSEC
8-K · Current reportApr 23, 2025Current reportSEC
424B5 · ProspectusApr 11, 2025Offer documentSEC
8-K · Current reportApr 2, 2025ResultsSEC
8-K · Current reportMar 27, 2025Current reportSEC
8-K · Current reportMar 26, 2025Acquisition or disposalSEC
8-K · Current reportMar 21, 2025Current reportSEC
8-K · Current reportMar 19, 2025Current reportSEC
8-K · Current reportMar 6, 2025Current reportSEC
424B5 · ProspectusFeb 26, 2025Offer documentSEC
8-K · Current reportFeb 25, 2025Material contractSEC
10-Q · Quarterly reportFeb 19, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
NT 10-Q · Late filing noticeFeb 14, 2025Explanation requestSEC
8-K · Current reportJan 17, 2025Current reportSEC
3 · Initial statement of ownershipJan 8, 2025Insider tradeSEC
8-K · Current reportDec 31, 2024Management or board changeSEC
8-K · Current reportNov 22, 2024Management or board changeSEC
SC 13G · Big-stake noticeNov 14, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 8, 2024Quarterly reportSEC
S-1 · Registration statementOct 25, 2024Offer documentSEC
ARS · Annual report to shareholdersOct 7, 2024Annual reportSEC
DEFA14A · Additional proxy materialOct 7, 2024Meeting noticeSEC
DEF 14A · Proxy statementOct 7, 2024Meeting noticeSEC
PRE 14A · Preliminary proxy statementSep 18, 2024Meeting noticeSEC
8-K · Current reportAug 9, 2024Management or board changeSEC
4 · Change in ownershipAug 9, 2024Insider tradeSEC
4 · Change in ownershipAug 9, 2024Insider tradeSEC
4 · Change in ownershipAug 9, 2024Insider tradeSEC
4 · Change in ownershipAug 9, 2024Insider tradeSEC
4 · Change in ownershipAug 9, 2024Insider tradeSEC
4 · Change in ownershipAug 7, 2024Insider tradeSEC
10-Q · Quarterly reportAug 5, 2024Quarterly reportSEC
10-K/A · Annual report, amendedJul 26, 2024Annual reportSEC
8-K · Current reportJul 24, 2024Current reportSEC
10-K · Annual reportMay 31, 2024Annual reportSEC
424B4 · ProspectusMay 14, 2024Offer documentSEC
8-K · Current reportMay 13, 2024Material contractSEC
424B4 · ProspectusMay 10, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveMay 9, 2024Other filingsSEC
CORRESP · Letter to the SECMay 3, 2024Other filingsSEC
CORRESP · Letter to the SECMay 3, 2024Other filingsSEC
8-K · Current reportMay 1, 2024Current reportSEC
S-1/A · Registration statement, amendedApr 30, 2024Offer documentSEC
8-K · Current reportApr 23, 2024Current reportSEC
UPLOAD · Letter from the SECApr 17, 2024Other filingsSEC
S-1 · Registration statementApr 12, 2024Offer documentSEC
SC 13G/A · Big-stake notice, amendedFeb 12, 2024Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveFeb 9, 2024Other filingsSEC
424B5 · ProspectusFeb 8, 2024Offer documentSEC
10-Q · Quarterly reportFeb 8, 2024Quarterly reportSEC
8-K · Current reportFeb 7, 2024Current reportSEC
CORRESP · Letter to the SECFeb 6, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedFeb 5, 2024Big-stake noticeSEC
UPLOAD · Letter from the SECFeb 2, 2024Other filingsSEC
S-3 · Registration statementJan 26, 2024Offer documentSEC
8-K · Current reportDec 28, 2023FinancingSEC
424B5 · ProspectusDec 22, 2023Offer documentSEC
S-8 · Registration statement for employee plansDec 1, 2023Offer documentSEC
4 · Change in ownershipNov 17, 2023Insider tradeSEC
4 · Change in ownershipNov 17, 2023Insider tradeSEC
4 · Change in ownershipNov 17, 2023Insider tradeSEC
4 · Change in ownershipNov 17, 2023Insider tradeSEC
4 · Change in ownershipNov 17, 2023Insider tradeSEC
4 · Change in ownershipNov 17, 2023Insider tradeSEC
144 · Notice of proposed saleNov 15, 2023Other filingsSEC
10-Q · Quarterly reportNov 9, 2023Quarterly reportSEC
8-K · Current reportNov 3, 2023Management or board changeSEC
8-K/A · Current report, amendedSep 22, 2023Management or board changeSEC
ARS · Annual report to shareholdersSep 13, 2023Annual reportSEC
DEF 14A · Proxy statementSep 13, 2023Meeting noticeSEC
DEFA14A · Additional proxy materialSep 13, 2023Meeting noticeSEC
8-K · Current reportSep 12, 2023Management or board changeSEC
8-K · Current reportSep 5, 2023Current reportSEC
8-K · Current reportAug 22, 2023Management or board changeSEC
10-Q · Quarterly reportAug 10, 2023Quarterly reportSEC
10-K/A · Annual report, amendedJul 31, 2023Annual reportSEC
8-K · Current reportJul 24, 2023Current reportSEC
PRE 14A · Preliminary proxy statementJul 14, 2023Meeting noticeSEC
10-K · Annual reportJul 13, 2023Annual reportSEC
NT 10-K · Late filing noticeJun 29, 2023Explanation requestSEC
8-K · Current reportMar 15, 2023Material contractSEC
SC 13G/A · Big-stake notice, amendedFeb 10, 2023Big-stake noticeSEC
10-Q · Quarterly reportFeb 9, 2023Quarterly reportSEC
SC 13G/A · Big-stake notice, amendedFeb 3, 2023Big-stake noticeSEC
4 · Change in ownershipNov 14, 2022Insider tradeSEC
4 · Change in ownershipNov 14, 2022Insider tradeSEC
4 · Change in ownershipNov 14, 2022Insider tradeSEC
4 · Change in ownershipNov 14, 2022Insider tradeSEC
4 · Change in ownershipNov 14, 2022Insider tradeSEC
4 · Change in ownershipNov 14, 2022Insider tradeSEC
10-Q · Quarterly reportNov 10, 2022Quarterly reportSEC
S-8 POSOct 25, 2022Offer documentSEC
S-8 POSOct 25, 2022Offer documentSEC
S-8 POSOct 25, 2022Offer documentSEC
S-8 POSOct 25, 2022Offer documentSEC
S-8 POSOct 25, 2022Offer documentSEC
S-8 · Registration statement for employee plansOct 25, 2022Offer documentSEC
4 · Change in ownershipOct 20, 2022Insider tradeSEC
4 · Change in ownershipOct 20, 2022Insider tradeSEC
4 · Change in ownershipOct 20, 2022Insider tradeSEC
8-K · Current reportOct 14, 2022Management or board changeSEC
DEFA14A · Additional proxy materialSep 22, 2022Meeting noticeSEC
DEFR14ASep 22, 2022Meeting noticeSEC
8-K · Current reportSep 6, 2022Current reportSEC
10-Q · Quarterly reportAug 11, 2022Quarterly reportSEC
DEFA14A · Additional proxy materialJul 26, 2022Meeting noticeSEC
DEF 14A · Proxy statementJul 26, 2022Meeting noticeSEC
5 · Annual statement of ownershipJul 8, 2022Insider tradeSEC
10-K · Annual reportJun 10, 2022Annual reportSEC
4 · Change in ownershipMar 10, 2022Insider tradeSEC
3 · Initial statement of ownershipMar 10, 2022Insider tradeSEC
8-K · Current reportMar 10, 2022Management or board changeSEC
8-K · Current reportFeb 28, 2022Material contractSEC
10-Q · Quarterly reportFeb 14, 2022Quarterly reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 10, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 4, 2022Big-stake noticeSEC
8-K · Current reportNov 19, 2021Material contractSEC
S-8 · Registration statement for employee plansNov 9, 2021Offer documentSEC
10-Q · Quarterly reportNov 8, 2021Quarterly reportSEC
3 · Initial statement of ownershipNov 1, 2021Insider tradeSEC
4 · Change in ownershipOct 12, 2021Insider tradeSEC
4 · Change in ownershipOct 12, 2021Insider tradeSEC
4 · Change in ownershipOct 12, 2021Insider tradeSEC
4 · Change in ownershipOct 12, 2021Insider tradeSEC
4 · Change in ownershipOct 12, 2021Insider tradeSEC
4 · Change in ownershipOct 12, 2021Insider tradeSEC
4 · Change in ownershipOct 12, 2021Insider tradeSEC
8-K · Current reportOct 6, 2021Management or board changeSEC
8-K · Current reportOct 1, 2021Current reportSEC
DEFA14A · Additional proxy materialSep 17, 2021Meeting noticeSEC
8-K · Current reportSep 17, 2021Current reportSEC
DEFA14A · Additional proxy materialAug 30, 2021Meeting noticeSEC
4 · Change in ownershipAug 19, 2021Insider tradeSEC
10-Q · Quarterly reportAug 6, 2021Quarterly reportSEC
DEFA14A · Additional proxy materialAug 5, 2021Meeting noticeSEC
DEF 14A · Proxy statementAug 5, 2021Meeting noticeSEC
10-K/A · Annual report, amendedJul 29, 2021Annual reportSEC
10-K · Annual reportJun 15, 2021Annual reportSEC
8-K · Current reportMay 13, 2021Management or board changeSEC
8-K · Current reportApr 19, 2021Management or board changeSEC
S-8 · Registration statement for employee plansMar 25, 2021Offer documentSEC

This page holds 200 of 820 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from VivoSim Labs, Inc.’s releases · as of Nov 1, 2026

Common shares
20,281,495
Fully diluted
20,281,495

Fully diluted

LineSharesAs of
Common shares20,281,495Nov 1, 2026

Warrants and options

Lot
Warrants · US$0.85 · expire about Jul 2031

Share count over time

CountShares
Nov 1, 202620,281,495

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Armistice Capital, LLC390K1.9%US$82,771Sep 30, 2026
Jane Street46,9860.23%US$9,961Sep 30, 2026
Vanguard22,3740.11%US$4,744Sep 30, 2026
Geode Capital20,1730.10%US$4,275Sep 30, 2026
TRUE Private Wealth Advisors10,8950.05%US$2,310Sep 30, 2026
BlackRock10,3420.05%US$2,193Sep 30, 2026
UBS9,1180.04%US$1,933Sep 30, 2026
Tower Research Capital LLC (TRC)6,0210.03%US$1,276Sep 30, 2026
Allworth Financial LP500<0.01%US$106Sep 30, 2026
SBI Securities Co., Ltd.221<0.01%US$47Sep 30, 2026
All 26 holders
HolderSharesOf the companyValueAs of
Larson Financial Group LLC166<0.01%US$35Sep 30, 2026
Albion Financial Group159<0.01%US$34Sep 30, 2026
Wells Fargo136<0.01%US$29Sep 30, 2026
Osaic Holdings, Inc.92<0.01%US$17Sep 30, 2026
Robinhood Markets, Inc.42<0.01%US$9Sep 30, 2026
Morgan Stanley41<0.01%US$9Sep 30, 2026
IFG Advisory, LLC14<0.01%US$3Sep 30, 2026
Jones Financial Companies Lllp8<0.01%US$2Sep 30, 2026
Pinnacle Financial Group, Inc.6<0.01%US$1Sep 30, 2026
Golden State Wealth Management, LLC2<0.01%Sep 30, 2026
Activest Wealth Management2<0.01%Sep 30, 2026
Rockefeller Capital Management L.P.2<0.01%Sep 30, 2026
Caitong International Asset Management Co., Ltd1<0.01%Sep 30, 2026
Hilton Head Capital Partners, LLC1<0.01%Sep 30, 2026
Harbour Investments, Inc.1<0.01%Sep 30, 2026
RBC1<0.01%Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Fidelity Extended Market Index Fund24,5440.12%US$32,153May 31, 2026
Vanguard Extended Market Index Fund15,3710.08%US$16,447Jun 30, 2026
Fidelity Series Total Market Index Fund4,0550.02%US$5,312May 31, 2026
Fidelity Total Market Index Fund991<0.01%US$1,298May 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Lialin Tony Serge
Officer: Chief Commercial Officer
Buy10,000USD 0.28US$2,800Aug 31, 2026

Big stakes

StakeStakeSharesDateFiling
Esousa Group Holdings LLC9.90%319KJun 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Adam Stern
Other companies: DarioHealth Corp. (Board Member · Since at least Mar 1, 2020); Cycurion, Inc. (Director · Jan 11, 2022 – Jan 11, 2022 · Past); Matinas BioPharma Holdings, Inc. (Director · May 16, 2019 – Aug 21, 2020 · Past)
Director · Since at least Jul 14, 2020
Steven George Hughes
Other companies: Atrium Therapeutics, Inc. (Chief Medical Officer · Since at least Feb 26, 2026); Avidity Biosciences, Inc (Chief Medical Officer · Since at least Jan 6, 2025); Arcturus Therapeutics Holdings Inc. (Chief Development Officer · Feb 18, 2020 – Dec 18, 2020 · Past)
Chief Medical Officer · Aug 1, 2018 – Aug 16, 2019 · Past
Tamar D Howson
Other companies: Immunic, Inc. (Director · Since at least Oct 11, 2019); Cue Biopharma, Inc. (Director · Sep 17, 2020 – Jan 3, 2023 · Past); Lite Strategy, Inc. (Director · Jul 1, 2019 – Sep 29, 2023 · Past)
Director · Jul 26, 2018 – Jul 26, 2018 · Past
Keith Murphy
Other companies: Matinas BioPharma Holdings, Inc. (Board Member · Since at least Mar 11, 2025); TuHURA Biosciences, Inc. (Director · Aug 19, 2020 – Sep 22, 2021 · Past)
Executive Chairman · Since at least Mar 13, 2012
Chris Heberlig
Other companies: Kiniksa Pharmaceuticals International, plc (EVP & CFO · May 23, 2018 – Sep 17, 2019 · Past)
President and CFO · Sep 15, 2020 – Sep 15, 2020 · Past
Norman Staskey
Other companies: Azitra Inc (Chief Financial Officer · Since at least Jun 15, 2023)
Chief Financial Officer · Since at least Dec 30, 2024
Richard Maroun
Other companies: Whitehawk Therapeutics, Inc. (Director · Since at least Aug 26, 2021)
Director · Aug 17, 2016 – Sep 5, 2019 · Past
Sharon Collins Presnell
Other companies: Viveve Medical, Inc. (Director · Oct 28, 2020 – Jan 3, 2023 · Past)
Chief Scientific Officer · Nov 16, 2017 – Nov 16, 2018 · Past
Alison MilhousDirector · Since at least Nov 17, 2023
Amar SethiChief Science Officer · Since at least Nov 24, 2025
All 17 people
PersonSeat
Craig KussmanChief Financial Officer · Aug 22, 2016 – Aug 18, 2020 · Past
David GobelDirector · Since at least Sep 15, 2020
Doug CohenChief Executive Officer · Since at least Nov 4, 2026
Douglas Jay CohenDirector · Since at least Jan 27, 2026
Thomas E JurgensenGeneral Counsel & Secretary · Mar 8, 2021 – Aug 31, 2022 · Past
Tony LialinChief Commercial Officer · Since at least Aug 14, 2025
Tony Serge LialinChief Commercial Officer · Since at least Aug 31, 2026

Open People

Log in to ask 6ix AI your own questions about VivoSim Labs, Inc.